M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction

Abstract M6A methylation is the most prevalent and abundant RNA modification in mammals. Although there are many studies on the regulatory role of m6A methylation in the immune response, the m6A regulators in the pathogenesis of acute ST-segment elevation myocardial infarction (STEMI) remain unclear...

Full description

Bibliographic Details
Main Authors: Jingqi Yang, Qing Shangguan, Guobo Xie, Ming Yang, Guotai Sheng
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-42959-5
_version_ 1797576678929596416
author Jingqi Yang
Qing Shangguan
Guobo Xie
Ming Yang
Guotai Sheng
author_facet Jingqi Yang
Qing Shangguan
Guobo Xie
Ming Yang
Guotai Sheng
author_sort Jingqi Yang
collection DOAJ
description Abstract M6A methylation is the most prevalent and abundant RNA modification in mammals. Although there are many studies on the regulatory role of m6A methylation in the immune response, the m6A regulators in the pathogenesis of acute ST-segment elevation myocardial infarction (STEMI) remain unclear. We comprehensively analysed the role of m6A regulators in STEMI and built a predictive model, revealing the relationship between m6A methylations and the immune microenvironment. Differential analysis revealed that 18 of 24 m6A regulators were significantly differentially expressed, and there were substantial interactions between the m6A regulator. Then, we established a classifier and nomogram model based on 6 m6A regulators, which can easily distinguish the STEMI and control samples. Finally, two distinct m6A subtypes were obtained and significantly differentially expressed in terms of infiltrating immunocyte abundance, immune reaction activity and human leukocyte antigen genes. Three hub m6A phenotype related genes (RAC2, RELA, and WAS) in the midnightblue module were identified by weighted gene coexpression network analysis, and were associated with immunity. These findings suggest that m6A modification and the immune microenvironment play a key role in the pathogenesis of STEMI.
first_indexed 2024-03-10T21:56:16Z
format Article
id doaj.art-28b78c33f7744a0aac6f73f5e3742b7a
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-10T21:56:16Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-28b78c33f7744a0aac6f73f5e3742b7a2023-11-19T13:06:19ZengNature PortfolioScientific Reports2045-23222023-09-0113111410.1038/s41598-023-42959-5M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarctionJingqi Yang0Qing Shangguan1Guobo Xie2Ming Yang3Guotai Sheng4Department of Cardiovascular Medicine, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical CollegeDepartment of Cardiovascular Medicine, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical CollegeDepartment of Cardiovascular Medicine, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical CollegeDepartment of Cardiovascular Medicine, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical CollegeDepartment of Cardiovascular Medicine, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical CollegeAbstract M6A methylation is the most prevalent and abundant RNA modification in mammals. Although there are many studies on the regulatory role of m6A methylation in the immune response, the m6A regulators in the pathogenesis of acute ST-segment elevation myocardial infarction (STEMI) remain unclear. We comprehensively analysed the role of m6A regulators in STEMI and built a predictive model, revealing the relationship between m6A methylations and the immune microenvironment. Differential analysis revealed that 18 of 24 m6A regulators were significantly differentially expressed, and there were substantial interactions between the m6A regulator. Then, we established a classifier and nomogram model based on 6 m6A regulators, which can easily distinguish the STEMI and control samples. Finally, two distinct m6A subtypes were obtained and significantly differentially expressed in terms of infiltrating immunocyte abundance, immune reaction activity and human leukocyte antigen genes. Three hub m6A phenotype related genes (RAC2, RELA, and WAS) in the midnightblue module were identified by weighted gene coexpression network analysis, and were associated with immunity. These findings suggest that m6A modification and the immune microenvironment play a key role in the pathogenesis of STEMI.https://doi.org/10.1038/s41598-023-42959-5
spellingShingle Jingqi Yang
Qing Shangguan
Guobo Xie
Ming Yang
Guotai Sheng
M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction
Scientific Reports
title M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction
title_full M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction
title_fullStr M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction
title_full_unstemmed M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction
title_short M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction
title_sort m6a regulator methylation patterns and characteristics of immunity in acute st segment elevation myocardial infarction
url https://doi.org/10.1038/s41598-023-42959-5
work_keys_str_mv AT jingqiyang m6aregulatormethylationpatternsandcharacteristicsofimmunityinacutestsegmentelevationmyocardialinfarction
AT qingshangguan m6aregulatormethylationpatternsandcharacteristicsofimmunityinacutestsegmentelevationmyocardialinfarction
AT guoboxie m6aregulatormethylationpatternsandcharacteristicsofimmunityinacutestsegmentelevationmyocardialinfarction
AT mingyang m6aregulatormethylationpatternsandcharacteristicsofimmunityinacutestsegmentelevationmyocardialinfarction
AT guotaisheng m6aregulatormethylationpatternsandcharacteristicsofimmunityinacutestsegmentelevationmyocardialinfarction